Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

25 sept. 2025 11h53 HE | Source: Spherix Global Insights

AbbVie’s Rinvoq Gains Early Traction in Giant Cell Arteritis Market, Expanding Options for Rheumatologists

EXTON, PA, Sept. 25, 2025 (GLOBE NEWSWIRE) -- Rheumatologists report high satisfaction with AbbVie’s Rinvoq (upadacitinib) following its recent approval in giant cell arteritis (GCA), with the...
14 nov. 2024 01h16 HE | Source: Global Center on Adaptation

GCA and AIIB Partner to Strengthen Climate Resilience in Infrastructure Projects

Baku, Azerbaijan, Nov. 14, 2024 (GLOBE NEWSWIRE) -- The Global Center on Adaptation (GCA) and the Asian Infrastructure Investment Bank (AIIB) have established a strategic partnership aimed at...
12 nov. 2019 16h01 HE | Source: Kiniksa Pharmaceuticals, Ltd.

Kiniksa Presents Preclinical Data on the Role of GM-CSF in GCA at the 2019 ACR/ARP Annual Meeting

- Mavrilimumab suppresses pathogenic immune responses in a validated in vivo model of medium and large vessel vasculitis - - Additional human ex vivo data support rationale for targeting GM-CSF in...